Vimarsana
Biggest News Aggregation in the World

Page 3 - Stuart Goldstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stuart Goldstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stuart Goldstein Today - Breaking & Trending Today

AcelRx Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

AcelRx Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Realigning cost structure from a focus on commercialization to a focus on development to advance late-stage pipeline; expected to result in annual savings of...

AcelRx Hosting Key Opinion Leader Webinar on Niyad™ Nafamostat Program - Vimarsana News

AcelRx Hosting Key Opinion Leader Webinar on Niyad™ Nafamostat Program

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
AcelRx Hosting Key Opinion Leader Webinar on Niyad™ - Vimarsana News

AcelRx Hosting Key Opinion Leader Webinar on Niyad™

Key Opinion Leaders participating will be Stuart Goldstein, MD, Cincinnati Children’s Hospital and Lakhmir Chawla, MD, former Chief of the Division of...

$20M Frankel Innovation Initiative Set to Kick off Third Round of Funding - Vimarsana News

$20M Frankel Innovation Initiative Set to Kick off Third Round of Funding

The Frankel Innovation Initiative is designed to build on best practices of the standout programs developed at U-M and other top institutions, and capitalizes on U-M’s extensive biomedical research enterprise. The $20 million gift is used to fund four to seven projects annually, with each project receiving between $250,000 - $500,000. Projects are eligible for up to three

AcelRx Pharmaceuticals Announces Publication of Clinical Data Finding Potential Benefits of Nafamostat Compared to Regional Citrate for Anticoagulation of the Dialysis Circuit - Vimarsana News

AcelRx Pharmaceuticals Announces Publication of Clinical Data Finding Potential Benefits of Nafamostat Compared to Regional Citrate for Anticoagulation of the Dialysis Circuit

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...